HEART Score Calculator

What Is the HEART Score?

The HEART score is a validated clinical risk stratification tool used in emergency departments to assess patients presenting with chest pain. It helps clinicians estimate the short-term risk of major adverse cardiac events (MACE), such as myocardial infarction or death, within the next six weeks. The score is calculated from five components: History, ECG, Age, Risk factors, and Troponin — forming the acronym HEART.

Each component is scored 0, 1, or 2, yielding a total score between 0 and 10. The result categorizes patients into low-risk (0–3), moderate-risk (4–6), or high-risk (7–10) groups, guiding decisions about admission, observation, or further testing.

How the HEART Score Is Calculated

The HEART score is derived from five clinical elements, each assessed independently:

• History (H): Based on the patient's description of chest pain. Highly suspicious symptoms score 2 points, moderately suspicious score 1, and non-suspicious score 0.
• ECG (E): Significant ST-segment depression scores 2 points, non-specific repolarization abnormalities score 1, and a normal ECG scores 0.
• Age (A): Patients aged 65 years or older score 2 points, those between 45 and 64 score 1, and those under 45 score 0.
• Risk factors (R): The presence of known cardiovascular risk factors (e.g., diabetes, smoking, hypertension, hypercholesterolemia, family history of coronary artery disease) determines the score. Three or more risk factors or a history of significant atherosclerotic disease scores 2 points, one or two risk factors scores 1, and no known risk factors scores 0.
• Troponin (T): Elevated troponin levels (at or above the 99th percentile of a normal reference population) score 2 points, borderline elevation scores 1, and normal levels score 0.

The total score is the sum of these five individual scores.

Interpreting the HEART Score Results

The total HEART score corresponds to a specific risk category for MACE within six weeks:

• Score 0–3 (Low risk): Approximately 0.9–1.7% risk of MACE. These patients are often considered safe for discharge or early outpatient follow-up without immediate intensive investigation.
• Score 4–6 (Moderate risk): Approximately 12–16% risk of MACE. These patients typically require observation, further diagnostic testing (e.g., stress testing or coronary imaging), and hospital admission.
• Score 7–10 (High risk): Approximately 50–65% risk of MACE. These patients generally require urgent cardiology consultation, admission, and often invasive management.

The HEART score is a decision-support tool, not a substitute for clinical judgment. Individual patient circumstances, comorbidities, and local protocols should always be considered.

Common Mistakes When Using the HEART Score

• Misinterpreting history: The history component should reflect the clinician's suspicion based on the full presentation, not just the presence of chest pain. Atypical presentations in women, elderly patients, or diabetics require careful assessment.
• Overlooking borderline troponin: Even mildly elevated troponin levels (score 1) increase risk. Using a binary normal/abnormal approach can underestimate risk.
• Ignoring age as a continuous variable: The age cutoff at 45 and 65 is a simplification. A 44-year-old with multiple risk factors may still be at significant risk despite a lower age score.
• Applying the score to unstable patients: The HEART score is validated for stable chest pain patients. It should not replace immediate life-saving interventions in hemodynamically unstable or clearly acute coronary syndrome presentations.

Limitations of the HEART Score

• The score was developed and validated primarily in emergency department populations in Europe and North America. Its performance may vary in other settings or populations.
• It does not account for all potential risk factors, such as chronic kidney disease, peripheral vascular disease, or prior coronary artery bypass grafting, which may independently increase risk.
• The troponin component depends on the assay used. Different assays have different thresholds and sensitivities, which can affect scoring.
• The HEART score is designed for short-term (six-week) risk prediction, not long-term cardiovascular risk assessment.

Practical Use Cases

• Emergency triage: Rapidly identify low-risk patients who may be suitable for early discharge, reducing unnecessary admissions and resource utilization.
• Clinical decision support: Provide a structured framework for junior clinicians or in busy settings where cognitive overload may lead to missed risk factors.
• Patient communication: Use the score to explain risk levels to patients and involve them in shared decision-making about further testing or observation.
• Quality improvement: Audit HEART score usage and outcomes to evaluate adherence to evidence-based chest pain pathways.